...
首页> 外文期刊>Medicine. >Evaluation of parenteral nutrition-associated liver disease in surgical infants for necrotizing enterocolitis
【24h】

Evaluation of parenteral nutrition-associated liver disease in surgical infants for necrotizing enterocolitis

机译:肠外营养相关肝病对坏死性小肠结肠炎的外科营养相关肝病

获取原文

摘要

The purpose of this study was to determine the factors associated with parenteral nutrition -associated liver disease (PNALD) in infants who underwent surgery for necrotizing enterocolitis (NEC) and followed up the postoperative outcomes for long term parenteral nutrition (PN). This study included a retrospective review of 87 infants with NEC and managed surgically from July 2007 to May 2017 at the Children's Hospital, Chongqing Medical University. Clinical data and procedure information were collected and analyzed. Among the infants included, 16.1% of patients developed PNALD. Multivariable logistic regression analysis revealed progressive clinical deterioration (OR, 5.47; 95% CI, 1.10–26.96; P = .037) was independent risk factor for PNALD whereas congenital heart disease (OR, 0.068; 95% CI, 0.008–0.55; P = .012) presentation served as a protective factor. The current data suggested the distinct disease process for cardiac patients with NEC, which might help in the prevention and treatment of PNALD for patients with NEC.
机译:本研究的目的是确定与肠外营养 - 分配的肝病(PNALD)相关的因素,婴儿接受坏死性小肠结肠炎(NEC)的手术,并随访长期肠外营养(PN)的术后结果。本研究包括回顾性审查87名婴儿,并于2007年7月至2017年7月在重庆医科大学儿童医院进行了外科医疗。收集和分析临床数据和程序信息。包括在内的婴儿中,16.1%的患者开发了大麻。多变量的逻辑回归分析显示进步临床劣化(或5.47; 95%CI,1.10-26.96; P = .037)是珍珠的独立风险因素,而先天性心脏病(或0.068; 95%CI,0.008-0.55; P. = .012)介绍用作保护因子。目前的数据表明了NEC的心脏病患者的不同疾病方法,这可能有助于NEC患者预防和治疗PNALD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号